Evidence map›Paper›PMID 26807497›Full record

ReviewRetinal cases & brief reports2016

OCULAR INVOLVEMENT IN HEMOPHAGOCYTIC SYNDROME: A NOVEL FUNDUSCOPIC MANIFESTATION AND REVIEW OF THE LITERATURE.

Kristin S Suhr, Michael F Chiang, John T Flynn, Michael Engelbert

Abstract readCase ReportsReview
In one paragraph

Review in Retinal cases & brief reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kristin S Suhr*New York University School of Medicine, New York, New York; †Casey Eye Institute, Portland, Oregon; ‡Edward S. Harkness Eye Institute, New York, New York; and §Vitreous-Retina-Macula Consultants of New York, New York, New York.
Michael F Chiang
John T Flynn
Michael Engelbert
Insall Scott Kelly Institute · USNew York University · USVitreous Retina Macula Consultants of New York · US

Funding

Telemedical Diagnosis of Retinopathy of PrematurityK23EY013972 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHIANG, MICHAEL · 2003 to 2007
$1.2M
NEI NIH HHS K23 EY013972
6 · The paper itself

Abstract

purposeHemophagocytic syndrome (HS) is a rare disease with a spectrum of ocular findings. The authors report a unique funduscopic presentation of HS in a neonate and a discussion of diagnosis, typical features, management, and outcome.

methodsSingle case report with retrospective analysis of the published literature of patients with HS and ocular findings from 1950 to present using the key terms hemophagocytic, lymphohistiocytosis, ocular, and ophthalmic. Literature search from 1950 to the present was performed through PubMed/MEDLINE and the Cochrane database. Requirement for inclusion was that the article or abstract was written in English.

resultsA 4-week-old neonate with HS demonstrated bilateral discrete white dots within the retina, which resolved incompletely over the course of the next months but showed increased pigmentation.

conclusionWith so few documented ophthalmic cases of HS in existence, the ocular findings at this point can be seen as diverse and variable. However as more cases are reported, hopefully this will allow for increased recognition of the ophthalmic manifestations and sequelae and in turn lead to improved treatment of this disease.

Indexed as

Fatal OutcomeFemaleHumansInfant, NewbornLymphohistiocytosis, HemophagocyticPigmentation DisordersRemission, SpontaneousRetinal DiseasesRetrospective Studies

Identifiers

PMID26807497
PMCPMC13359079
OpenAlexW2322015084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.